DrugPatentWatch Database Preview
CLINICAL TRIALS PROFILE FOR BUPRENEX
All Clinical Trials for Buprenex
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT01324544 | Pharmacokinetics, Safety, and Efficacy of Intravenous Dosing of Buprenorphine in Pediatric Patients Who Require Opioid Analgesia for Acute Moderate to Severe Pain | Withdrawn | Purdue Pharma LP | Phase 3 | 2011-11-01 | The purpose of this study is to characterize the safety, pharmacokinetics (PK), and efficacy of intravenous (IV) buprenorphine in pediatric patients. |
NCT01407575 | Buprenorphine for Treatment Resistant Depression | Completed | National Alliance for Research on Schizophrenia and Depression | Phase 3 | 2011-09-01 | The purpose of this study is to compare the safety and efficacy of buprenorphine with placebo for adults with treatment resistant depression (TRD). |
NCT01407575 | Buprenorphine for Treatment Resistant Depression | Completed | University of Pittsburgh | Phase 3 | 2011-09-01 | The purpose of this study is to compare the safety and efficacy of buprenorphine with placebo for adults with treatment resistant depression (TRD). |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Buprenex
Condition Name
Condition MeSH
Clinical Trial Locations for Buprenex
Trials by Country
Clinical Trial Progress for Buprenex
Clinical Trial Phase
Clinical Trial Sponsors for Buprenex
Sponsor Name